Indiana Senate committee advances bill to restrict intoxicating hemp products ahead of federal THC changes

Proposal targets hemp-derived cannabinoids like delta-8 and THCA

Indiana lawmakers began advancing legislation that would significantly narrow what hemp-derived THC products can be legally sold in the state, as federal policy shifts toward tighter restrictions later this year. Senate Bill 250, authored by Sen. Aaron Freeman of Indianapolis, cleared its first committee vote on Jan. 15, 2026, moving out of the Senate Commerce and Technology Committee on a 7-2 party-line roll call.

The bill is aimed at intoxicating hemp derivatives that have proliferated in retail markets since hemp was legalized under a federal definition tied to delta-9 THC concentration. That approach, which sets hemp apart from marijuana based on a 0.3% delta-9 THC threshold by dry weight, has allowed products made with other cannabinoids—such as delta-8 THC and THCA—to be sold in many jurisdictions, including Indiana.

Aligning Indiana law with federal limits now scheduled for late 2026

The proposal would revise Indiana’s approach to THC by adopting a broader counting method and imposing tight caps on THC content in finished consumer products. The legislation mirrors federal provisions adopted in a stopgap federal funding measure enacted in November 2025. Under those federal provisions, all forms of THC are counted toward compliance, total THC in a final product is capped at 0.4 milligrams per container, and lab-made cannabinoids are prohibited.

SB 250 would put similar limits into Indiana law earlier than the federal timeline. The federal changes are scheduled to take effect in November 2026, while the Indiana proposal sets an earlier effective date of July 2026.

Tax provision removed; bill now heads to Appropriations

During committee consideration, lawmakers adopted an amendment removing an excise tax component. Under Indiana’s legislative rules, revenue-raising provisions must originate in the House, not the Senate. With that change, the measure advanced but still faces additional procedural and policy scrutiny.

The bill’s next stop is the Senate Appropriations Committee, where fiscal impacts and implementation questions are typically examined before legislation moves to the full Senate for debate and a floor vote.

Competing pressures: youth protections, industry disruption, and uncertain federal next steps

In committee testimony, prosecutors and public-safety officials backed tighter limits, describing the marketplace as having moved far beyond what policymakers intended when hemp definitions were adopted. Supporters framed the bill as a way to create clearer rules, reduce access by minors, and address enforcement challenges tied to intoxicating products sold outside the state’s marijuana laws.

Opponents and industry representatives raised concerns about the pace and breadth of the proposed restrictions, warning that the policy could quickly disrupt businesses that have operated under the existing hemp framework. At the federal level, a separate effort has been introduced to delay implementation of the November 2025 THC restrictions until 2028—an uncertainty that could affect how states time and design their own laws.

• SB 250 advanced from Senate Commerce and Technology on Jan. 15, 2026.
• It would apply broad THC counting and strict per-container limits, and prohibit lab-made cannabinoids.
• The bill must clear Senate Appropriations before reaching the full Senate.

Indiana has debated regulating or banning intoxicating hemp products in recent years, but past proposals have stalled. SB 250 is the latest attempt to establish a durable statewide framework as federal rules tighten.